Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Reddy's Laboratories Limited
  6. Summary
    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
07/22/2021 07/23/2021 07/26/2021 07/27/2021 07/28/2021 Date
5382.85 5422.9 5409.15 4844.35 4730.2 Last
7070 12685 6992 236548 179933 Volume
+0.80% +0.74% -0.25% -10.44% -2.36% Change
Estimated financial data (e)
Sales 2022 223 B 2 991 M 2 991 M
Net income 2022 29 810 M 400 M 400 M
Net cash position 2022 26 788 M 359 M 359 M
P/E ratio 2022 26,1x
Yield 2022 0,58%
Sales 2023 244 B 3 279 M 3 279 M
Net income 2023 37 400 M 502 M 502 M
Net cash position 2023 41 126 M 552 M 552 M
P/E ratio 2023 21,3x
Yield 2023 0,63%
Capitalization 784 B 10 530 M 10 526 M
EV / Sales 2022 3,40x
EV / Sales 2023 3,04x
Nbr of Employees 22 739
Free-Float 66,7%
More Financials
Company
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed... 
Sector
Pharmaceuticals
Calendar
07/28Shareholder meeting
More about the company
Ratings of Dr. Reddy's Laboratories Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DR. REDDY'S LABORATORIES LIMITED
01:42aIndian shares fall as banks and pharma drag; IMF cuts growth forecast
RE
07/27DR REDDY LABORATORIES : . Reddy's Q1 FY22 Financial Results (Form 6-K)
PU
07/27DR REDDY LABORATORIES : Report of Independent Registered Public Accounting Firm ..
PU
07/27Asian ADRs Move Sharply Lower in Tuesday Trading
MT
07/27DR REDDY LABORATORIES : Multi-service mobile app platform brings together doctor..
PU
07/27DR REDDY LABORATORIES' : Consolidated Net Profit Slips in Fiscal Q1
MT
07/27Indian Benchmarks Settle in Red on Tuesday; Dr Reddy's Laboratories Tanks 10%
MT
07/27DR REDDY LABORATORIES : Unit Ties Up with ICICI Lombard to Launch Cashless Outpa..
MT
07/27DOCTOR REDDY'S : Fiscal Q1 Earnings Snapshot
AQ
07/27DR REDDY LABORATORIES : . Reddy's Q1 FY22 Financial Results
PU
07/23Asian ADRs Down Almost 2% as China Education Stocks Slump on Crackdown Fears
MT
07/22Asian ADRs Move Lower in Thursday Trading
MT
07/20Asian ADRs Rebound 0.4% Tuesday
MT
07/19Asian ADRs Down 2.2% Monday Amid Global Sell-Off
MT
07/16Asian ADRs Move Lower in Friday Trading
MT
More news
News in other languages on DR. REDDY'S LABORATORIES LIMITED
07/12ASTRAZENECA : La vacunación en India se retrasa por la escasez de la segunda dos..
04/27Merck ermöglicht indischen Generikaherstellern Zugang zu Covid-19-Kandidaten
04/12DR REDDY LABORATORIES : Coronavirus-L'Inde approuve le vaccin russe Sputnik V
2019INDIVIOR : paie cher sa dépendance au Subutex
More news
Analyst Recommendations on DR. REDDY'S LABORATORIES LIMITED
More recommendations
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | 500124 | INE089A01023 | MarketScreener
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Last Close Price 4 730,20 INR
Average target price 5 501,70 INR
Spread / Average Target 16,3%
EPS Revisions
Managers and Directors
Erez Israeli Chief Executive Officer
Parag Agarwal Chief Financial Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Mukesh Rathi Chief Digital & Information Officer
Sector and Competitors
1st jan.Capi. (M$)
DR. REDDY'S LABORATORIES LIMITED-9.11%10 780
JOHNSON & JOHNSON9.71%454 682
ROCHE HOLDING AG11.50%329 752
PFIZER, INC.14.37%235 663
NOVARTIS AG-0.44%221 987
ELI LILLY AND COMPANY44.27%221 420